| Issuer | % of Class | Filed | ||||
|---|---|---|---|---|---|---|
| Schedule 13G · 1 security · passive | ||||||
|
Artiva Biotherapeutics, Inc.
13G/A
ARTV · 04317A107
|
4.9% |
5/15/2025
Event 3/31/2025
|
||||
| venBio Global Strategic Fund III, L.P. | 4.9% | |||||
| Venbio Global Strategic GP III, L.P. | 4.9% | |||||
| Venbio Global Strategic GP III, Ltd | 4.9% | |||||
| Adelman Robert J | 4.9% | |||||
| Goodman Corey S | 4.9% | |||||
Includes filings since 12/18/2024, when the SEC began requiring structured 13D and 13G data.